Literature DB >> 5058642

Toxicity profile of chloroacetaldehyde.

W H Lawrence, E O Dillingham, J E Turner, J Autian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5058642     DOI： 10.1002/jps.2600610103

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  3 in total

1.  The effect of route of administration and fractionation of dose on the metabolism of ifosfamide.

Authors:  M J Lind; H L Roberts; N Thatcher; J R Idle
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.

Authors:  V Kurowski; T Wagner
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Mutagenicity of chloroacetaldehyde, a possible metabolic product of 1,2-dichloroethane (ethylene dichloride), chloroethanol (ethylene chlorohydrin), vinyl chloride, and cyclophosphamide.

Authors:  J McCann; V Simmon; D Streitwieser; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.